Sacroiliac Joint Injection: Diagnosis, Treatment & Recovery
Interventional Spine and Pain Management Physician, Chief of the Division of Pain Medicine at Good Samaritan University Hospital, and Founder of SpinePain Solutions. Dr. Sharma completed pain-medicine fellowship training at Johns Hopkins and has practiced interventional pain medicine since 2004.
A sacroiliac joint injection, often called an SI-joint injection, is an image-guided procedure used to evaluate or treat pain suspected to arise from the sacroiliac joint. The joint lies where the sacrum at the base of the spine meets the ilium of the pelvis.
SI-joint pain can overlap with lumbar, hip, buttock, groin and leg pain. The injection is most useful when it answers a defined clinical question. Local anesthetic may provide diagnostic information; corticosteroid, when included, is intended to provide therapeutic anti-inflammatory benefit.
Immediate anesthetic relief and later steroid relief are not the same outcome. The anesthetic response helps evaluate whether numbing the joint changes the usual pain. A later steroid response measures therapeutic benefit. Neither result should be interpreted without the examination, technical details and competing pain sources.
What Is a Sacroiliac Joint Injection?
A thin needle is advanced to the SI joint using fluoroscopic or CT guidance. Contrast is commonly used to confirm the intended location before medication is delivered. Depending on the purpose, the injectate may contain local anesthetic alone or local anesthetic with corticosteroid.
- Diagnostic purpose: determine whether temporarily numbing the joint changes the patient’s familiar pain and function.
- Therapeutic purpose: attempt to reduce inflammation and improve activity using corticosteroid when clinically appropriate.
- Combined purpose: collect diagnostic information during the anesthetic period while also observing whether a later therapeutic response occurs.
Where Is the Sacroiliac Joint?
The paired SI joints connect the sacrum to the left and right sides of the pelvis and help transfer load between the trunk and legs. The joint cavity, capsule, posterior ligaments and nearby nerve-supplied tissues can all contribute to SI-joint complex pain.
An intra-articular injection primarily evaluates or treats the joint cavity. It does not fully test every ligament, muscle or posterior nerve-related structure in the broader SI-joint complex.
Symptoms That May Suggest SI-Joint Pain
SI-joint pain is often centered below L5 near one side of the posterior pelvis or buttock. It may be aggravated by:
- Rising from a chair or getting out of a car
- Climbing stairs
- Rolling over in bed
- Prolonged standing or sitting
- Standing or loading on one leg
- Pregnancy-related changes, pelvic trauma or altered mechanics after lumbar fusion
Pain may spread into the hip, groin, thigh or leg, but symptoms alone do not identify the source. Review the full SI-joint pain diagnosis guide for provocation tests, imaging limitations and competing diagnoses.
SI-Joint Pain Versus Sciatica, Facet Pain and Hip Pain
| Possible source | Common pattern | Important clues |
|---|---|---|
| SI-joint complex | Pain below the beltline near the buttock or posterior pelvis, sometimes groin or thigh referral | Pain with transitions, stairs, rolling in bed or single-leg loading; several concordant provocation tests |
| Sciatica or radiculopathy | Burning, shooting or electric leg pain, often below the knee | Numbness, tingling, weakness, reflex change or a coherent nerve-root distribution |
| Facet-mediated pain | Low-back stiffness with buttock or upper-thigh referral | Often worse with extension, standing or rotation |
| Hip-joint pain | Groin or anterior-thigh pain, sometimes buttock pain | Restricted or painful hip rotation, difficulty putting on shoes or entering a car |
For a focused comparison, see sciatica versus SI-joint pain and facet joint syndrome.
How SI-Joint Pain Is Evaluated Before Injection
No single pain location, examination test or MRI proves that the SI joint is the pain generator. The evaluation generally combines:
- The location and behavior of the patient’s familiar pain
- Several SI-joint provocation maneuvers that reproduce that familiar pain
- Lumbar, hip and neurological examination
- Imaging when needed to assess inflammatory disease, fracture, infection, tumor or competing pathology
- An image-guided injection when the result will change treatment
Common provocation maneuvers include FABER, thigh thrust, compression, distraction, Gaenslen’s test and sacral thrust. A concordant cluster increases suspicion, but the injection result must still be interpreted with its technical and biological limitations.
Why Image Guidance Matters
The SI joint is deep, narrow and irregular. Fluoroscopy or CT guidance improves the ability to place the needle at the intended target. Contrast can document intra-articular spread and reveal unintended vascular or extra-articular flow before therapeutic medication is delivered.
Technical accuracy improves interpretability, but it does not eliminate anesthetic spread, false-positive responses, false-negative responses or pain arising outside the joint cavity.
Diagnostic Versus Therapeutic SI-Joint Injection
Diagnostic SI-Joint Injection
A diagnostic injection uses local anesthetic to test whether temporarily numbing the joint changes the patient’s usual pain. The most useful comparison is made against a baseline pain score and predefined activity, using the same scale during the expected medication window.
Therapeutic SI-Joint Injection
A therapeutic injection includes corticosteroid when clinically appropriate. Benefit may develop over several days and varies in magnitude and duration. It should be integrated with rehabilitation and treatment of coexisting lumbar, hip or gait problems rather than presented as a cure.
How Much Relief From an SI-Joint Injection Confirms the Diagnosis?
Relief of the patient’s usual pain during the expected local-anesthetic period, while repeating a normally painful activity, is more informative than a percentage recalled weeks later. Contemporary multispecialty guidance uses at least 50% for certain diagnostic or prognostic decisions, while the Medicare LCD used by New York’s contractor requires at least 75% for a positive diagnostic SI-joint injection. The threshold depends on what is being tested and which clinical or coverage decision follows.
Why 50% and 75% Both Appear
- Clinical diagnostic or prognostic threshold: the 2025 multispecialty guideline supports at least 50% relief for certain SI-joint diagnostic or prognostic blocks, including selection for sacral lateral-branch RFA.
- Medicare diagnostic coverage threshold: NGS LCD L39455, which applies in New York, requires at least 75% relief for a positive diagnostic SI-joint injection under that policy.
- Subsequent therapeutic injection: the same LCD requires at least 50% sustained pain relief or functional improvement for at least three months when judging benefit from the prior therapeutic injection.
- RFA or fusion selection: the appropriate target, prognostic block, number of blocks and threshold can differ. An intra-articular injection is not universal clearance for either procedure.
These numbers answer different questions and should not be blended into one definition of success. A coverage requirement is not biological proof, and payer policies may change. The applicable policy should be checked for the individual patient and proposed treatment.
Separate the Anesthetic Response From the Steroid Response
The local anesthetic is assessed during its expected short duration of action. Improvement within that window supports the diagnostic inference. Corticosteroid, when included, may begin helping over subsequent days and is intended to provide therapeutic benefit. Later steroid improvement does not answer the same diagnostic question as immediate anesthetic relief.
Use a Pain-and-Activity Diary
Choose the index pain and two or three normally painful activities before the injection. Use the same pain scale each time and test only activities permitted by the discharge instructions.
| Time | Pain score | Activity tested | Change from baseline |
|---|---|---|---|
| Before injection | ___ / 10 | Sit-to-stand, stairs or walking | Baseline |
| Immediately after | ___ / 10 | Same activity | ___% |
| During expected anesthetic window | ___ / 10 | Same activity | ___% |
| Later that day | ___ / 10 | Same activity if permitted | ___% |
| Following days if steroid was used | ___ / 10 | Usual daily function | Duration and function |
Why the Result Can Be Misleading
Anesthetic spread outside the joint, placebo and expectation effects, sedation, medication changes, unusually low activity and another nearby pain generator can alter the apparent response. A technically accurate, low-volume, image-guided injection improves interpretability but does not eliminate false-positive or false-negative results.
An intra-articular injection primarily tests the joint cavity. The posterior SI-joint complex includes ligaments and nerve-supplied structures outside that cavity, so a negative intra-articular block does not necessarily exclude all posterior SI-joint complex pain. Conversely, strong temporary relief does not prove that the SI joint is the only pain generator or guarantee that RFA or fusion will succeed.
What If the Result Is Weak or Unclear?
Reassess whether the injection reached the intended target, whether the patient tested the usual pain during the correct time window and whether the hip, lumbar spine, nerve roots or another posterior pelvic structure may be contributing. An unclear result should not automatically trigger a repeat injection or an invasive next step.
Who May Be a Candidate?
An SI-joint injection may be considered when:
- Pain is centered below L5 near the posterior pelvis or buttock.
- Several provocation maneuvers reproduce the patient’s familiar pain.
- Lumbar, hip and neurological causes have been reasonably evaluated.
- Symptoms remain function-limiting despite appropriate initial care.
- The injection result will influence the diagnosis or treatment plan.
- Infection, bleeding, medication and contrast risks are acceptable.
A favorable pain location alone is not enough. The procedure is less informative when the pain is diffuse, the usual painful activity cannot be identified, heavy sedation prevents reliable reporting or another diagnosis already explains the symptoms more convincingly.
How to Prepare
- Review anticoagulants, antiplatelet drugs, diabetes medications, antibiotics, supplements and allergies with the treating team.
- Do not stop prescribed medication unless the clinician managing it provides instructions.
- Report fever, active infection, a new antibiotic prescription, pregnancy or possible pregnancy.
- Follow individualized eating, drinking and transportation instructions.
- Identify the usual pain and two or three safe activities to test after the injection.
- Record the baseline pain score immediately before the procedure using the same scale planned for follow-up.
See the detailed guide to preparing for a spine or joint injection.
How the Procedure Is Performed
- The patient is positioned, commonly face down, and the target area is confirmed.
- The skin is cleaned using sterile technique.
- Local anesthetic is used to numb the skin and superficial tissues.
- A needle is advanced toward the intended SI-joint target using fluoroscopic or CT guidance.
- Contrast is typically used to confirm placement and evaluate spread.
- Local anesthetic and, when appropriate, corticosteroid are injected.
- The patient is monitored and receives individualized discharge instructions.
The needle portion is often brief, but the full visit includes preparation, positioning, imaging, monitoring and discharge. Sedation, when used, can extend recovery and may affect interpretation of a diagnostic response.
What to Expect After the Injection
- Temporary numbness, heaviness or weakness may occur if anesthetic reaches nearby nerves.
- The injection site may be sore, and pain may temporarily flare.
- Follow the treating team’s activity, bathing, dressing and driving instructions.
- Do not drive after sedation or while numbness, weakness or impaired reaction time persists.
- During the anesthetic window, repeat only the predefined activities that are safe and permitted.
- If steroid was used, continue tracking pain and function over the following days.
Contact the treating team for severe or escalating pain, fever, drainage, spreading redness, persistent new weakness or numbness, bowel or bladder changes, or another concerning symptom. Emergency symptoms require urgent assessment.
Risks and Limitations
Potential risks include:
- Temporary soreness or pain flare
- Bleeding, bruising or hematoma
- Infection
- Medication, antiseptic or contrast reaction
- Temporary numbness or weakness
- Elevated blood glucose, flushing, sleep disturbance or other corticosteroid effects
- Nerve injury or other serious complication, which is uncommon but possible
- No meaningful pain relief
- A false-positive, false-negative or technically inconclusive diagnostic result
An SI-joint injection does not repair mechanical instability, reverse degeneration or treat lumbar nerve compression. Repeated corticosteroid exposure also requires individualized risk-benefit review.
What Research and Guidelines Say
The 2025 multispecialty consensus guideline concludes that intra-articular injections have diagnostic validity for pain arising inside the SI joint, but not for every extra-articular source in the posterior SI-joint complex. It also emphasizes the limited ability of imaging or physical examination alone to identify the pain generator.
The guideline found that corticosteroid injections may provide short-term relief in appropriately selected patients, but treatment durability varies. Evidence for PRP and prolotherapy is weak, and injection response should not be converted into a guarantee about RFA or fusion.
For coverage in New York, NGS LCD L39455 currently requires at least 75% relief for a positive diagnostic SI-joint injection. It uses a different standard for a subsequent therapeutic injection: at least 50% sustained pain relief or functional improvement for at least three months after the prior therapeutic injection. These are Medicare coverage rules, not universal medical definitions, and they should be rechecked when treatment is planned.
What If Relief Is Brief or the Injection Does Not Help?
Reassess the Diagnostic Question
A weak or inconsistent response may reflect an incorrect target, extra-articular SI-joint complex pain, medication spread, an atypical activity level or a competing lumbar, hip, nerve or muscular source. The next step should address that uncertainty rather than automatically repeating the injection.
Sacral Lateral-Branch RFA
SI-joint RFA targets posterior sacral lateral-branch innervation and is conceptually different from an intra-articular injection or fusion. Evidence, anatomy, the diagnostic or prognostic block strategy and insurance coverage should be reviewed for each patient. New York Medicare’s current SI-joint injection LCD does not cover SI-joint denervation, although other payer policies differ.
PRP, Prolotherapy and BMAC
Orthobiologic procedures are not substitutes for a diagnostic local-anesthetic block. Evidence for SI-joint pain remains limited, preparations and techniques vary, and insurance coverage is often absent. These procedures should not be presented as proven to regenerate, stabilize or permanently repair the SI joint. See PRP for SI-joint pain.
SI-Joint Fusion
SI-joint fusion is a later option for carefully selected patients with persistent, function-limiting pain that has been reasonably localized to the SI joint despite appropriate nonsurgical care. A favorable injection is only one part of candidacy and does not guarantee the result. Procedure approach, evidence, risks and recovery require a separate discussion.
When an SI-Joint Injection May Not Be the Right Procedure
The procedure is less likely to answer the clinical question when symptoms are better explained by:
- Lumbar disc herniation or spinal stenosis with concordant nerve compression
- Radiculopathy with a coherent neurological pattern
- Facet-mediated pain
- Hip arthritis or another hip disorder
- Peripheral neuropathy or focal peripheral-nerve pain
- Diffuse or predominantly muscular pain
- Fracture, infection, tumor or inflammatory disease requiring a different pathway
An injection may also need to be postponed or modified because of active infection, medication or contrast allergy, anticoagulation, uncontrolled medical risk or pregnancy. These decisions are individualized.
SI-Joint Treatment Pathway: Choose What Fits Best
⚡ Sciatica / Leg Nerve Pain
🦴 Facet Joint / Back Arthritis Pain
🔥 SI-Joint RFA Discussion
🩸 PRP / Orthobiologic Options
🧭 Not Sure? Start With Back Pain
Frequently Asked Questions About Sacroiliac Joint Injection
What is a sacroiliac joint injection?
A sacroiliac joint injection is an image-guided procedure that places local anesthetic and, when appropriate, corticosteroid into the SI joint. The anesthetic response may provide diagnostic evidence, while corticosteroid is intended to provide therapeutic anti-inflammatory benefit.
Is an SI-joint injection diagnostic or therapeutic?
It may be diagnostic, therapeutic or both. Improvement during the expected local-anesthetic window supports an intra-articular SI-joint pain source. Any later corticosteroid response addresses therapeutic benefit and should not be treated as identical to the immediate diagnostic response.
How much relief from an SI-joint injection confirms the diagnosis?
There is no single percentage that confirms every SI-joint diagnosis or qualifies a patient for every subsequent treatment. Relief of the usual pain during the expected local-anesthetic window, while repeating a normally painful activity, is most informative. Many clinical protocols use at least 50% relief for certain diagnostic or prognostic blocks, while some insurer policies require 75%. The threshold, duration, technical accuracy, functional change and purpose of the block must be interpreted together.
How soon will I feel relief after an SI-joint injection?
Local anesthetic may change pain within minutes, but its duration depends on the medication used. Corticosteroid benefit, when it occurs, may begin over the following several days. Temporary soreness or a short pain flare may occur before improvement.
How long does relief from an SI-joint injection last?
Duration varies. A diagnostic anesthetic response is expected to be temporary. Therapeutic benefit from corticosteroid may be brief or may last longer in selected patients, but it is not guaranteed. Diagnosis, pain mechanism, activity, rehabilitation and competing conditions all influence the result.
Is an SI-joint injection safe?
SI-joint injections are commonly performed with imaging guidance and sterile technique, but no injection is risk-free. Possible risks include soreness, temporary pain flare, bleeding, infection, medication or contrast reaction, temporary numbness or weakness, steroid-related effects and failure to improve. Serious neurological injury is uncommon but possible.
Do I need sedation for an SI-joint injection?
Many SI-joint injections can be performed with local anesthetic alone. Sedation is individualized. Because sedation can change pain reporting and activity during a diagnostic block, its effect on interpretation should be considered. If sedation is used, transportation and driving restrictions apply.
What if an SI-joint injection does not provide lasting relief?
The next step depends on whether the immediate diagnostic response was convincing, whether later therapeutic benefit occurred and whether another pain generator is present. Options may include rehabilitation, treatment of a lumbar or hip source, another injection in selected circumstances, sacral lateral-branch evaluation, or carefully selected fusion assessment.
Does a positive SI-joint injection guarantee that RFA or fusion will work?
No. An intra-articular injection tests pain arising from the joint cavity and may not predict treatment of the posterior lateral branches. A favorable injection also does not guarantee fusion success. The target, block strategy, functional response, competing diagnoses, evidence and applicable coverage policy must be considered separately.
Can PRP or BMAC be used for SI-joint pain?
PRP, prolotherapy and bone marrow aspirate concentrate are different from a standard diagnostic or corticosteroid injection. Evidence for orthobiologic treatment of SI-joint pain remains limited, product and technique differences matter, and insurance coverage is often absent. These procedures should not be presented as proven to regenerate or permanently repair the SI joint.
References
- McCormick ZL, et al. Consensus practice guidelines on sacroiliac joint complex pain from a multispecialty, international working group. Regional Anesthesia & Pain Medicine. 2025. Read the full guideline.
- Sayed D, et al. American Society of Pain and Neuroscience best practice guideline for the treatment of sacroiliac disorders. Journal of Pain Research. 2024. Read the guideline.
- Centers for Medicare & Medicaid Services. Sacroiliac Joint Injections and Procedures, NGS LCD L39455. Accessed September 14, 2026. Review the current LCD.
Dr. Amit Sharma & our minimally invasive pain & spine team.
